C&EN Whitepaper
Potential and Challenges of Manufacturing Pharmaceutical Products of Natural Origins
Brought to you by BioVectra
Overview

Producing drugs derived from natural products often require more specialized process design than other types of medicines. Experienced manufacturers bring to bear a range of technologies as processes are adapted for scaling up, improving efficiency, controlling impurities, reducing environmental impact, and more.

Key Objectives:
  • Understanding process design for naturally derived pharmaceutical products.  
  • Understanding FDA objectives for achieving manufacturing quality standards.
  • Understanding how manufacturers use product “fingerprints” to assess purity.
  • Understanding how adaptive process design can improve manufacturing bottlenecks.

Brought to you by:
BioVectra
Potential and Challenges of Manufacturing Pharmaceutical Products of Natural Origins
Please complete the form to download the whitepaper.
By completing and submitting this form, you understand and agree that use of American Chemical Society (ACS) websites are subject to the ACS Terms of Use and ACS Privacy Policy, including the fact that ACS and its third party sponsors can contact you based on the information provided. In order to process your registration completely, you understand that your information will be transferred to ACS’ affiliates globally.

Copyright © 2024 American Chemical Society | 1155 Sixteenth Street NW | Washington, DC 20036 | View our Privacy Policy